FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vassiliki Poulaki

Research Profile

Chemicals & Drugs

Anatomy

Tumor Cells, Cultured

Physiology

Disorders

Living Beings

Co-author Network

Publications

TOP 3
Nicholas Mitsiades; Aline I Riechardt; Sue Anne Chew; Bin He; Theano Karadedou; Vassiliki Kotoula; Vassiliki Poulaki
Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy.
Eirini Iliaki; Vassiliki Poulaki; Nicholas Mitsiades; Constantine S Mitsiades; Joan W Miller; Evangelos S Gragoudas
Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
Vassiliki Poulaki; Constantine S Mitsiades; Vassiliki Kotoula; Joseph Negri; Ciaran McMullan; Joan W Miller; Paul A Marks; Nicholas Mitsiades
Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vassiliki Poulaki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Nicholas Mitsiades; Aline I Riechardt; Sue Anne Chew; Bin He; Theano Karadedou; Vassiliki Kotoula; Vassiliki Poulaki
Genotype-dependent sensitivity of uveal melanoma cell lines to inhibition of B-Raf, MEK, and Akt kinases: rationale for personalized therapy.
Investigative ophthalmology & visual science 2011;52(10):7248-55.
2009: Eirini Iliaki; Vassiliki Poulaki; Nicholas Mitsiades; Constantine S Mitsiades; Joan W Miller; Evangelos S Gragoudas
Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
Investigative ophthalmology & visual science 2009;50(10):4898-904.
2009: Vassiliki Poulaki; Constantine S Mitsiades; Vassiliki Kotoula; Joseph Negri; Ciaran McMullan; Joan W Miller; Paul A Marks; Nicholas Mitsiades
Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.
Investigative ophthalmology & visual science 2009;50(9):4072-9.
2009: Antonia M Joussen; Sven Doehmen; Minh L Le; Kan Koizumi; Sven Radetzky; Tim Krohne; Vassiliki Poulaki; Irina Semkova; Norbert Kociok
TNF-alpha mediated apoptosis plays an important role in the development of early diabetic retinopathy and long-term histopathological alterations.
Molecular vision 2009;15():1418-28.
2007: Constantine S Mitsiades; Patrick J Hayden; Vassiliki Kotoula; Douglas W McMillin; Ciaran McMullan; Joseph Negri; Jake E Delmore; Vassiliki Poulaki; Nicholas Mitsiades
Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.
The Journal of clinical endocrinology and metabolism 2007;92(12):4845-52.
2007: Vassiliki Poulaki; Constantine S Mitsiades; Vassiliki Kotoula; Joseph Negri; Douglas W McMillin; Joan W Miller; Nicholas Mitsiades
The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
Investigative ophthalmology & visual science 2007;48(10):4706-19.
2007: Vassiliki Poulaki; Eirini Iliaki; Nicholas Mitsiades; Constantine S Mitsiades; Yannis Paulus; Deisy V Bula; Evangelos S Gragoudas; Joan W Miller
Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(9):2113-23.
2007: Constantine S Mitsiades; Joseph Negri; Ciaran McMullan; Douglas W McMillin; Elias Sozopoulos; Galinos Fanourakis; Gerassimos Voutsinas; Sofia Tseleni-Balafouta; Vassiliki Poulaki; David Batt; Nicholas Mitsiades
Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.
Molecular cancer therapeutics 2007;6(3):1070-8.
2007: Ali Hafezi-Moghadam; Kousuke Noda; L Almulki; Eirini Iliaki; Vassiliki Poulaki; Kennard L Thomas; T Nakazawa; Toshio Hisatomi; Joan W Miller; Evangelos S Gragoudas
VLA-4 blockade suppresses endotoxin-induced uveitis: in vivo evidence for functional integrin up-regulation.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2007;21(2):464-74.
2007: Norbert Kociok; Tim Krohne; Vassiliki Poulaki; Antonia M Joussen
Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2007;245(2):258-66.
2006: Constantine S Mitsiades; Douglas W McMillin; Vassiliki Kotoula; Vassiliki Poulaki; Ciaran McMullan; Joseph Negri; Galinos Fanourakis; Sofia Tseleni-Balafouta; Kenneth B Ain; Nicholas Mitsiades
Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.
The Journal of clinical endocrinology and metabolism 2006;91(10):4013-21.
2006: Constantine S Mitsiades; Vassiliki Kotoula; Vassiliki Poulaki; Elias Sozopoulos; Joseph Negri; Elpida Charalambous; Galinos Fanourakis; Gerassimos Voutsinas; Sofia Tseleni-Balafouta; Nicholas Mitsiades
Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.
The Journal of clinical endocrinology and metabolism 2006;91(9):3662-6.
2006: Irina Semkova; Sascha Fauser; Alexandra Lappas; Neil Smyth; Norbert Kociok; Bernd Kirchhof; Mats Paulsson; Vassiliki Poulaki; Antonia M Joussen
Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(10):1689-91.
2006: Constantine S Mitsiades; Vassiliki Poulaki; Galinos Fanourakis; Elias Sozopoulos; Douglas W McMillin; Zhaoqin Wen; Gerassimos Voutsinas; Sofia Tseleni-Balafouta; Nicholas Mitsiades
Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(12):3705-12.
2006: Constantine S Mitsiades; Nicholas Mitsiades; Ciaran McMullan; Vassiliki Poulaki; Andrew L Kung; Faith E Davies; Gareth Morgan; Masaharu Akiyama; Reshma Shringarpure; Nikhil C Munshi; Paul G Richardson; Teru Hideshima; Dharminder Chauhan; Xuesong Gu; Charles Bailey; Marie Joseph; Towia Libermann; Neal Rosen; Kenneth C Anderson
Antimyeloma activity of heat shock protein-90 inhibition.
Blood 2006;107(3):1092-100.
2005: Constantine S Mitsiades; Vassiliki Poulaki; Ciaran McMullan; Joseph Negri; Galinos Fanourakis; Athina Goudopoulou; Victoria M Richon; Paul A Marks; Nicholas Mitsiades
Novel histone deacetylase inhibitors in the treatment of thyroid cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(10):3958-65.
2005: Vassiliki Poulaki; Constantine S Mitsiades; Ciaran McMullan; Galinos Fanourakis; Joseph Negri; Athina Goudopoulou; Ioannis X Halikias; Gerassimos Voutsinas; Sofia Tseleni-Balafouta; Joan W Miller; Nicholas Mitsiades
Human retinoblastoma cells are resistant to apoptosis induced by death receptors: role of caspase-8 gene silencing.
Investigative ophthalmology & visual science 2005;46(1):358-66.
2004: Antonia M Joussen; Vassiliki Poulaki; Minh Ly Le; Kan Koizumi; Christina Esser; Hanna Janicki; Ulrich Schraermeyer; Norbert Kociok; Sascha Fauser; Bernd Kirchhof; Timothy S Kern; Anthony P Adamis
A central role for inflammation in the pathogenesis of diabetic retinopathy.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(12):1450-2.
2004: Vassiliki Poulaki; Antonia M Joussen; Nicholas Mitsiades; Constantine S Mitsiades; Eirini Iliaki; Anthony P Adamis
Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy.
The American journal of pathology 2004;165(2):457-69.
2004: Vassiliki Poulaki; Nicholas Mitsiades; Friedrich E Kruse; Sven Radetzky; Eirini Iliaki; Bernd Kirchhof; Antonia M Joussen
Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression.
The American journal of pathology 2004;164(4):1293-302.
2004: Constantine S Mitsiades; Nicholas Mitsiades; Ciaran McMullan; Vassiliki Poulaki; Reshma Shringarpure; Masaharu Akiyama; Teru Hideshima; Dharminder Chauhan; Marie Joseph; Towia Libermann; Carlos García-Echeverría; Mark A Pearson; Francesco Hofmann; Kenneth C Anderson; Andrew L Kung
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors.
Cancer cell 2004;5(3):221-30.
2004: Tomohiko Usui; Susumu Ishida; Kenji Yamashiro; Yuichi Kaji; Vassiliki Poulaki; Johnny Moore; Tara Moore; Shiro Amano; Yoshitaka Horikawa; Darlene A Dartt; Matthew Golding; David T Shima; Anthony P Adamis
VEGF164(165) as the pathological isoform: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2.
Investigative ophthalmology & visual science 2004;45(2):368-74.
2004: Constantine S Mitsiades; Nicholas Mitsiades; Ciaran McMullan; Vassiliki Poulaki; Reshma Shringarpure; Teru Hideshima; Masaharu Akiyama; Dharminder Chauhan; Nikhil C Munshi; Xuesong Gu; Charles Bailey; Marie Joseph; Towia Libermann; Victoria M Richon; Paul A Marks; Kenneth C Anderson
Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(2):540-5.
2003: Vassiliki Poulaki; Constantine S Mitsiades; Ciaran McMullan; Despoina Sykoutri; Galinos Fanourakis; Vassiliki Kotoula; Sofia Tseleni-Balafouta; Demetrios A Koutras; Nicholas Mitsiades
Regulation of vascular endothelial growth factor expression by insulin-like growth factor I in thyroid carcinomas.
The Journal of clinical endocrinology and metabolism 2003;88(11):5392-8.
2003: Constantine S Mitsiades; Despoina Sykoutri; Ciaran McMullan; Vassiliki Poulaki; Nicholas Mitsiades
Effect of imatinib mesylate (Gleevec) on anaplastic thyroid carcinoma cell lines.
The Journal of clinical endocrinology and metabolism 2003;88(10):5043-4; author reply 5044.
2003: Tara C B Moore; Jonathan E Moore; Yuichi Kaji; Norma Frizzell; Tomohiko Usui; Vassiliki Poulaki; Iain L Campbell; Alan Stitt; Tom A Gardiner; Desmond B Archer; Anthony P Adamis
The role of advanced glycation end products in retinal microvascular leukostasis.
Investigative ophthalmology & visual science 2003;44(10):4457-64.
2003: Constantine S Mitsiades; Vassiliki Poulaki; Nicholas Mitsiades
The role of apoptosis-inducing receptors of the tumor necrosis factor family in thyroid cancer.
The Journal of endocrinology 2003;178(2):205-16.
2003: Vassiliki Poulaki
Microdissection, microarrays and proteomics: a new approach to the study of eye diseases.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2003;241(7):527-8.
2003: Nicholas Mitsiades; Constantine S Mitsiades; Paul G Richardson; Ciaran McMullan; Vassiliki Poulaki; Galinos Fanourakis; Robert Schlossman; Dharminder Chauhan; Nikhil C Munshi; Teru Hideshima; Victoria M Richon; Paul A Marks; Kenneth C Anderson
Molecular sequelae of histone deacetylase inhibition in human malignant B cells.
Blood 2003;101(10):4055-62.
2003: Kan Koizumi; Vassiliki Poulaki; Sven Doehmen; Gerhard Welsandt; Sven Radetzky; Alexandra Lappas; Norbert Kociok; Bernd Kirchhof; Antonia M Joussen
Contribution of TNF-alpha to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo.
Investigative ophthalmology & visual science 2003;44(5):2184-91.
2003: Nicholas Mitsiades; Constantine S Mitsiades; Paul G Richardson; Vassiliki Poulaki; Yu-Tzu Tai; Dharminder Chauhan; Galinos Fanourakis; Xuesong Gu; Charles Bailey; Marie Joseph; Towia Libermann; Robert Schlossman; Nikhil C Munshi; Teru Hideshima; Kenneth C Anderson
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications.
Blood 2003;101(6):2377-80.
2003: Antonia M Joussen; Vassiliki Poulaki; Nicholas Mitsiades; Stephen U Stechschulte; Bernd Kirchhof; Darlene A Dartt; Guo-Hua Fong; John S Rudge; Stanley J Wiegand; George D Yancopoulos; Anthony P Adamis
VEGF-dependent conjunctivalization of the corneal surface.
Investigative ophthalmology & visual science 2003;44(1):117-23.
2003: Antonia M Joussen; Vassiliki Poulaki; Nicholas Mitsiades; Wen-yi Cai; Izumi Suzuma; John Pak; Shyr-Te Ju; Susan L Rook; Peter Esser; Constantine S Mitsiades; Bernd Kirchhof; Anthony P Adamis; Lloyd Paul Aiello
Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(1):76-8.
2002: Vassiliki Poulaki; Constantine S Mitsiades; Antonia M Joussen; Alexandra Lappas; Bernd Kirchhof; Nicholas Mitsiades
Constitutive nuclear factor-kappaB activity is crucial for human retinoblastoma cell viability.
The American journal of pathology 2002;161(6):2229-40.
2002: Nicholas Mitsiades; Constantine S Mitsiades; Vassiliki Poulaki; Dharminder Chauhan; Galinos Fanourakis; Xuesong Gu; Charles Bailey; Marie Joseph; Towia Libermann; Steve P Treon; Nikhil C Munshi; Paul G Richardson; Teru Hideshima; Kenneth C Anderson
Molecular sequelae of proteasome inhibition in human multiple myeloma cells.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(22):14374-9.
2002: Constantine S Mitsiades; Nicholas Mitsiades; Vassiliki Poulaki; Robert Schlossman; Masaharu Akiyama; Dharminder Chauhan; Teru Hideshima; Steve P Treon; Nikhil C Munshi; Paul G Richardson; Kenneth C Anderson
Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.
Oncogene 2002;21(37):5673-83.
2002: Vassiliki Poulaki; Constantine S Mitsiades; Vassiliki Kotoula; Sofia Tseleni-Balafouta; Avi Ashkenazi; Demetrios A Koutras; Nicholas Mitsiades
Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells.
The American journal of pathology 2002;161(2):643-54.
2002: Nicholas Mitsiades; Constantine S Mitsiades; Vassiliki Poulaki; Dharminder Chauhan; Paul G Richardson; Teru Hideshima; Nikhil C Munshi; Steve P Treon; Kenneth C Anderson
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications.
Blood 2002;99(12):4525-30.
2002: Nicholas Mitsiades; Constantine S Mitsiades; Vassiliki Poulaki; Dharminder Chauhan; Paul G Richardson; Teru Hideshima; Nikhil C Munshi; Steve P Treon; Kenneth C Anderson
Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications.
Blood 2002;99(11):4079-86.
2002: Antonia M Joussen; Vassiliki Poulaki; Akitaka Tsujikawa; Wenying Qin; Tamim Qaum; Qingwen Xu; Yasufumi Moromizato; Sven-Erik Bursell; Stanley J Wiegand; John S Rudge; Ella Ioffe; George D Yancopoulos; Anthony P Adamis
Suppression of diabetic retinopathy with angiopoietin-1.
The American journal of pathology 2002;160(5):1683-93.
2002: Nicholas Mitsiades; Constantine S Mitsiades; Vassiliki Poulaki; Kenneth C Anderson; Steve P Treon
Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells.
Blood 2002;99(6):2162-71.
2002: Vassiliki Poulaki
BMS-275291. Bristol-Myers Squibb.
Current opinion in investigational drugs (London, England : 2000) 2002;3(3):500-4.
2002: Vassiliki Poulaki; Wenying Qin; Antonia M Joussen; Peter Hurlbut; Stanley J Wiegand; John S Rudge; George D Yancopoulos; Anthony P Adamis
Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.
The Journal of clinical investigation 2002;109(6):805-15.
2002: Antonia M Joussen; Vassiliki Poulaki; Nicholas Mitsiades; Bernd Kirchhof; Kan Koizumi; Sven Döhmen; Anthony P Adamis
Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2002;16(3):438-40.
2002: Antonia M Joussen; Vassiliki Poulaki; Wenying Qin; Bernd Kirchhof; Nicholas Mitsiades; Stanley J Wiegand; John S Rudge; George D Yancopoulos; Anthony P Adamis
Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
The American journal of pathology 2002;160(2):501-9.
2001: A M Joussen; S Huang; Vassiliki Poulaki; Kevin A. Camphausen; Wolf-Dietrich Beecken; B Kirchhof; A P Adamis
In vivo retinal gene expression in early diabetes.
Investigative ophthalmology & visual science 2001;42(12):3047-57.
2001: Nicholas Mitsiades; Vassiliki Poulaki; Constantine S Mitsiades; Demetrios A Koutras; George Chrousos
Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases.
Trends in endocrinology and metabolism: TEM 2001;12(9):384-90.
2001: Antonia M Joussen; Wolf-Dietrich Beecken; Yasufumi Moromizato; A Schwartz; Bernd Kirchhof; Vassiliki Poulaki
Inhibition of inflammatory corneal angiogenesis by TNP-470.
Investigative ophthalmology & visual science 2001;42(11):2510-6.
2001: Vassiliki Poulaki; C S Mitsiades; Nicholas Mitsiades
The role of Fas and FasL as mediators of anticancer chemotherapy.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2001;4(4):233-42.
2001: Nicholas Mitsiades; Constantine S Mitsiades; Vassiliki Poulaki; Kenneth C Anderson; Steve P Treon
Concepts in the use of TRAIL/Apo2L: an emerging biotherapy for myeloma and other neoplasias.
Expert opinion on investigational drugs 2001;10(8):1521-30.
2001: Stephen U Stechschulte; Antonia M Joussen; H A von Recum; Vassiliki Poulaki; Yasufumi Moromizato; J Yuan; Robert J D'Amato; C Kuo; Anthony P Adamis
Rapid ocular angiogenic control via naked DNA delivery to cornea.
Investigative ophthalmology & visual science 2001;42(9):1975-9.
2001: Vassiliki Poulaki; Nicholas Mitsiades; Maria E Romero; Maria Tsokos
Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.
Cancer research 2001;61(12):4864-72.
2001: Nicholas Mitsiades; Vassiliki Poulaki; Constantine S Mitsiades; Kenneth C Anderson
Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug.
Expert opinion on investigational drugs 2001;10(6):1075-84.
2001: Vassiliki Poulaki; N Mitsiades; G Mastorakos; R R Caspi; George Chrousos; Evrydiki A Bouzas
Fas/Fas ligand-associated apoptosis in experimental autoimmune uveoretinitis in rodents: role of proinflammatory corticotropin-releasing hormone.
Experimental eye research 2001;72(6):623-9.
2001: A Leone; Nicholas Mitsiades; Yvona Ward; Beth Spinelli; Vassiliki Poulaki; Maria Tsokos; Kathleen Kelly
The Gem GTP-binding protein promotes morphological differentiation in neuroblastoma.
Oncogene 2001;20(25):3217-25.
2001: Nicholas Mitsiades; Vassiliki Poulaki; C Mitsiades; Maria Tsokos
Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
Cancer research 2001;61(6):2704-12.
2001: Catherine Schwesinger; C Yee; Richard M Rohan; A M Joussen; A Fernandez; Tobias N Meyer; Vassiliki Poulaki; J J Ma; T M Redmond; S Liu; Anthony P Adamis; Robert J D'Amato
Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.
The American journal of pathology 2001;158(3):1161-72.
2001: Nicholas Mitsiades; W H Yu; Vassiliki Poulaki; M Tsokos; Ivan Stamenkovic
Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.
Cancer research 2001;61(2):577-81.
2000: Nicholas Mitsiades; Vassiliki Poulaki; Sofia Tseleni-Balafouta; Demetrios A Koutras; Ivan Stamenkovic
Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Cancer research 2000;60(15):4122-9.
2000: N Mitsiades; Vassiliki Poulaki; Sofia Tseleni-Balafouta; George Chrousos; Demetrios A Koutras
Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease.
Thyroid : official journal of the American Thyroid Association 2000;10(7):527-32.
1999: Nicholas Mitsiades; Vassiliki Poulaki; A Leone; Maria Tsokos
Fas-mediated apoptosis in Ewing's sarcoma cell lines by metalloproteinase inhibitors.
Journal of the National Cancer Institute 1999;91(19):1678-84.
1999: Nicholas Mitsiades; Vassiliki Poulaki; George Mastorakos; Sofia Tseleni-Balafouta; Vassiliki Kotoula; Demetrios A Koutras; Maria Tsokos
Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion.
The Journal of clinical endocrinology and metabolism 1999;84(8):2924-32.
1998: Nicholas Mitsiades; Vassiliki Poulaki; Vassiliki Kotoula; A Leone; Maria Tsokos
Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase.
The American journal of pathology 1998;153(6):1947-56.
1998: Nicholas Mitsiades; Vassiliki Poulaki; Vassiliki Kotoula; George Mastorakos; Sofia Tseleni-Balafouta; Demetrios A Koutras; Maria Tsokos
Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis.
The Journal of clinical endocrinology and metabolism 1998;83(6):2199-203.